CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients
Year: 2021
Type: article
Source: European Neurology
DOI: 10.1159/000517770
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3188323733
